“Treatment interruption of biological drugs and tofacitinib in rheumatoid arthritis: A systematic review of case reports”, Braz. J. Pharm. Sci., vol. 54, no. 4, p. e17437, Dec. 2018, doi: 10.1590/s2175-97902018000417437.